Investigation of illicit pregabalin in seized samples from Saudi Arabia

IntroductionPregabalin (PGL) is a medication that is prescribed for controlling specific neurological-related symptoms. Due to its abuse in multiple countries, PGL has been classified as a controlled substance by authorities, including the Saudi Food and Drug Authority (SFDA).MethodsThis study devel...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatimah M. Alamri, Sultan K. Alshmmari, Monerah A. Altamimy, Ibrahim A. Al Othaim, Yahya M. Alshehri, Rayed M. Alafraa, Ahmed D. Almalki, Turki A. Alkhalifah, Taher Sahlabji, Abubakr M. Idris, Haitham Al-Hamoud, Yahya F. Jamous, Fahad S. Aldawasri
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Chemistry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2025.1594567/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionPregabalin (PGL) is a medication that is prescribed for controlling specific neurological-related symptoms. Due to its abuse in multiple countries, PGL has been classified as a controlled substance by authorities, including the Saudi Food and Drug Authority (SFDA).MethodsThis study developed a validated ultra-performance liquid chromatography-photodiode array detector (UPLC-PDA) method to quantify PGL in 40 seized samples (35 capsules, 5 powders). A complementary liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was used to detect potential adulterants.ResultsThe UPLC-PDA method demonstrated linearity (r = 0.9973) for PGL quantification (0.50–3.00 mg/mL), with an accuracy of 96%–102%. The RSD% values were 0.63% and 1.03% for intra-day and inter-day precision, respectively. Analysis of the five powder samples revealed a relative inconsistency in PGL content (107.91%–114.55%). Moreover, it showed higher variability in PGL content (RSD 1.16%–5.30%), suggesting possible adulteration or poor manufacturing. Furthermore, the results of the nuclear magnetic resonance (NMR) showed an acceptable purity for the powder samples. On the other hand, among 35 capsules, 5 (14.29%) exceeded pharmacopeial limits (95%–105% PGL content), while 6 (17.14%) contained <95% PGL.DiscussionThese results demonstrate significant variability in PGL content and the presence of adulterants, underscoring the need for robust analytical methods in forensic chemistry. Furthermore, the LC-MS/MS method detected adulteration of PGL with codeine, paracetamol, and gabapentin in 2.9% of the analyzed capsules, suggesting custom mixing by perpetrators. In general, 31.43% of these samples failed to meet quality standards and contained substances beyond declared contents that posed toxicity risks, revealing inadequacies in illicit drug production and circulation. The UPLC-PDA method offers a rapid, validated approach for PGL quantification, while LC-MS/MS enhances adulterant detection, supporting forensic and quality control applications.
ISSN:2296-2646